Innovate (VATE) shares soared nearly 61% amid heavy trading after the company said late Friday that the US Food and Drug Administration approved its MediBeacon platform to assess kidney function.
Over 17.4 million shares traded intraday versus a daily average of roughly 43,000.
Redwire (RDW) said Monday that it agreed to acquire Edge Autonomy in a cash and stock deal worth $925 million, expanding its space platforms portfolio.
Shares of Redwire advanced 43% as intraday trading volume soared to more than 7.9 million from a daily average of about 888,000.
Moderna (MRNA) disclosed late Friday a $590 million award by the US Department of Health and Human Services to accelerate the development of mRNA-based pandemic influenza vaccines.
Shares jumped 6.5%, with intraday trading volume rising to over 9.4 million compared with a daily average of about 9.1 million.
Price: 8.22, Change: +3.11, Percent Change: +60.86
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。